Company Long-Term Indebtedness: Exagen Inc. (XGN)

Public company logo of Exagen (XGN)

The asset value of Exagen Inc. (XGN), as reflected in the chart, is based on the operations of US laboratories that develop unique tests for rheumatological monitoring. Exagen Inc. (XGN) aims to expand its presence in the autoimmune pathology diagnostics sector through the implementation of the AVISE system. Long-term debt stands at 0.03, while profitability is constrained by the stringent policies of insurance organizations, which limit the final profit from specialized research.

XGN Exagen Diagnostics: Company Long-Term Debt in the range 07/04/2022 - 10/31/2026

Summary analytical data breakdowns for Exagen (XGN)

- market price and analyst price targets:
Stock Price Exagen Inc|XGN - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Exagen Inc.|XGN - Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Exagen Inc.|XGN - Company Book Value|Market Value to Book Value Ratio exagen.com|XGN - Cumulative Company Assets
- business debt structure and liquidity details:
Debt to Capital Exagen Inc.|XGN - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Exagen Inc|XGN - Company Aggregate Debts|Debts to Net Assets Exagen Inc.|XGN - Company Long-Term Debt|Short-Term Debt Volume Exagen Inc.|Immediate Liquidity exagen.com
- business earnings and investment ratios data:
XGN - Net Income
Summary company analytics:XGN Exagen Inc.
Manufactured product of Exagen Inc.

Long-term debt measures the total obligations of a company with a maturity of more than one year, reflecting the capital raising strategy used for scaling. This metric allows an investor to distinguish sustainable growth from dangerous credit overheating. By analyzing the level of long-term debt, one can assess the financial risks of expansion. For Exagen Inc. (XGN), this is critical during the modernization of the AVISE platform for ultra-precise diagnostics of autoimmune pathologies.

Competitors of Exagen Inc. (XGN)

Company Long-Term Debts agilent.com A|DGX - Company Long-Term Debt|ILMN (Illumina Inc) - Company Long-Term Indebtedness|EXAS: Company Long-Term Debts|Revvity Corp (RVTY) - Company Long-Term Debts|Company Long-Term Debt Bio-Rad Laboratories|Company Long-Term Debt NNNN|Company Long-Term Liabilities SHC (Sotera Health)|QDEL - Long-Term Debt|Company Long-Term Debt OPKO Corp OPK|Long-Term Debt Volume CareDx (CDNA)|Maravai LifeSciences - Company Long-Term Debts|Long-Term Debt Volume fulgentgenetics.com FLGT|Standard BioTools (LAB) - Company Long-Term Debt|CTKB - Long-Term Debt Volume|OSUR (OraSure Technologies Inc) - Company Long-Term Debts|Long-Term Debt MDxHealth, Inc. MDXH|Company Long-Term Liabilities LUCD (Lucid Diagnostics Inc.)|prenetics.com - Company Long-Term Indebtedness|Company Long-Term Debts IMDX (Insight Molecular Diagnostics Inc)|Company Long-Term Debts Trinity Biotech PLC TRIB|ProPhase - Company Long-Term Debts|Long-Term Indebtedness Ainos Corporation (AIMD)|CODX: Company Long-Term Debts|Long-Term Debt heartsciences.com (HSCS)|Company Long-Term Debt Biomerica|Company Long-Term Indebtedness CDIO (Cardio Diagnostics Holdings, Inc.)|Company Long-Term Liabilities VRAX (Virax Biolabs Group Ltd)|BJDX (Bluejay Diagnostics Corp) - Company Long-Term Loans and Borrowings|Company Long-Term Debts AWH (Aspira Women's Health)|Long-Term Debt Volume acceleratediagnostics.com (AXDX)|CNTG - Company Long-Term Debt|ENZ (Enzo Biochem, Inc.) - Company Long-Term Indebtedness|FRES: Company Long-Term Debts|Company Long-Term Liabilities Genetic Technologies Limited|Company Long-Term Liabilities ME|psychemedics.com (PMD) - Long-Term Debt Volume